Biophytis SA is a France-based biotechnology company focused on the development of therapeutics that slow the degenerative processes associated with aging and improve functional outcomes for patients suffering from age-related diseases. The company's drug candidate, Sarconeos (BIO101), is an orally administered small molecule in development for the treatment of neuromuscular diseases, including sarcopenia and DMD.Biophytis is a biotechnology company. It is engaged in the treatment of age-related illnesses and develops first-in-class drugs to treat degenerative illnesses associated with aging and treatment to restore muscular & visual functions.